提高台湾医疗保健的可持续性:关于国家药物政策改革的德尔菲研究
Chih-Fen Huang1, Kuan-Lin Chen2, Fang-Ju Lin3
1Department of Pharmacy, National Taiwan University Hospital, Taipei, Taiwan; School of Pharmacy, College of Medicine, National Taiwan University, Taipei, Taiwan.
台湾国家药物政策 (NMP) 需要改革,以改善药物获取和合理使用. 专家共识确定了关键问题,并为可持续的医疗保健和制药服务提出了54个可行的建议.
科学领域:
- 卫生政策 卫生政策
- 制药科学 制药科学
- 公共卫生 公共卫生
背景情况:
- 国家药物政策 (NMP) 对可获得,负担得起,高质量的药物及其合理使用至关重要.
- 有效的NMP对于公共卫生和医疗保健系统效率至关重要.
研究的目的:
- 评估台湾目前的国家药物政策.
- 确定NMP改进的关键领域.
- 为可持续的药物供应和使用制定专家认可的,可行的建议.
主要方法:
- 使用了一种经过修改的两轮德尔菲技术.
- 来自药房,医学,公共卫生和制药行业的50名专家组成的小组参加了会议.
- 一个4点的利克特级别评估了NMP的关键问题和政策建议的可行性和有效性.
主要成果:
- 确定了台湾国家药物计划中的13个关键问题,重点是药物可访问性和合理使用.
- 提出了54个政策改进建议,其中有20个强烈建议和23个温和建议.
- 建议涵盖药品报销,药房服务,管理,立法和教育.
结论:
- 台湾的NMP需要紧急改革,以确保高质量的药物和制药服务.
- 具体的政策建议旨在支持台湾国家健康保险 (NHI) 系统的可持续运行.
- 积极的措施对于在不断变化的环境中加强医疗保健的可持续性至关重要.
更多相关视频
05:59An In Vitro Dissolution Determination of Multi-Index Components in Tibetan Medicine Rhodiola Granules
Published on: November 4, 2022
09:16Author Spotlight: Optimization of Processing Technology for Tiebangchui with Zanba Based on CRITIC Combined with Box-Behnken Response Surface Method
Published on: May 12, 2023
相关概念视频
Methods Of Healthcare Delivery System
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is...
Primary Healthcare Services
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...
Introduction To Health Care Delivery System
The Institute of Medicine (IOM) advocates for a patient-centered, effective, safe, timely, equitable, and effective healthcare system. The National Priorities...
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Drug Control Governance: Regulatory Bodies and Their Impact
Drug Regulation
